Peptic ulcer bleeding outcomes adversely affected by end-stage renal disease.
Tsai
Jai-Jen
JJ
Lin
Hwai-Jeng
HJ
D000284:Administration, Oral; D015897:Comorbidity; D004305:Dose-Response Relationship, Drug; D004837:Epinephrine / Q000008:administration & dosage; D006801:Humans; D007262:Infusions, Intravenous; D015552:Injections, Intralesional; D007676:Kidney Failure, Chronic / Q000150:complications*; D007902:Length of Stay; D009853:Omeprazole / Q000008:administration & dosage*; D010438:Peptic Ulcer Hemorrhage / Q000188:drug therapy*; D054328:Proton Pump Inhibitors / Q000008:administration & dosage*; D055502:Secondary Prevention
D054328:Proton Pump Inhibitors; D009853:Omeprazole; D004837:Epinephrine